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Introduction 
At the present time successful 
clinical organ transplantation de-
pends on chronic administration of 
immunosuppressive agents to pre-
vent the persistent tendency of the 
recipient to reject the graft. Chronic 
immunosuppression- although of-
ten successful in maintaining graft 
function and viability-is frequently 
associated with numerous and often 
fatal complications. These associ-
ated problems include: 1) inherent 
tox1c1ty of immunosuppressive 
drugs per se, e.g., lmuran (hepati-
tis), steroids (osteoporosis, gastro-
intestinal bleeding, etc.) , Cytoxan 
and actinomycin C ( thrombocyto-
penia, leukopenia) ; 2) occurrence 
and persistence of low-grade rejec-
tion in the graft, e.g., endarteritis 
in renal and cardiac allografts, 
while function is maintained; 3) oc-
currence of severe and bizarre in-
fections, usually those associated 
with cellular immunity (particularly 
of the viral, protozoan and fungal 
varieties); and, finally, 4) spon-
taneous appearance of malignancy, 
presumably due to the abolition of 
the immunological surveillance 
mechanism which is probably op-
erative in preventing the de nova 
appearance of malignancy in most 
normal human beings. For these 
reasons specific immunological tol-
erance remains the ultimate and 
eventual solution to the widespread 
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McGuire Lecture Series, October 31-
November 1, 1968, Medical College 
of Virginia, Richmond. 
application of clinical organ trans-
plantation. 
Immunological Tolerance 
The phenomenon of actively ac-
quired immunological tolerance was 
discovered during studies of tissue 
transplantation. This term was used 
to describe a specific state of un-
responsiveness to an antigen or an-
tigens in adult life as a conse-
quence of exposure to antigen in 
utero or in the neonatal period. In 
a study of the immunogenetic con-
sequences of vascular anastomoses 
between cattle twins in utero, Owen 
( 1945) showed that most cattle 
twins at birth are erythrocyte chi-
meras as they possess erythro-
cytes of their own genotype as well 
as those of the opposite twin. This 
chimeric state was shown to persist 
beyond the life span of the eryth-
rocyte, suggesting that erythro-
poietic cells (stem cells) were ex-
changed in fetal life and continued 
to produce erythrocytes of char-
acteristic serological type through-
out adult life. 
The wide significance of Owen's 
observation was emphasized by 
Burnet and Fenner (1948) in a 
general theory of the immune re-
sponse which predicted the phe-
nomenon of tolerance. To explain 
the failure of adult animals to re-
act immunologically to their own 
tissues, these authors suggested that 
the body cells possess some type of 
self-marker component, and that 
the capacity to recognize this self 
pattern develops during embryonic 
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or early postnatal life. They pre-
dicted that exposure to an antigen 
in embryonic life would cause that 
antigen to be recognized as self 
in later life, and, consequently, no 
immune response would be made to 
it. 
In future studies, it became ap-
parent that erythrocyte chimerism 
was not the only manifestation of 
tolerance in dizygotic cattle twins 
which appeared after mixture of 
placental circulations. Dizygotic 
cattle twins were shown to accept 
skin grafts from each other, and 
this mutual tolerance was specific 
since skin grafts transplanted from 
third parties were quickly rejected 
(Anderson et al., 1951). These ob-
servations in nature set the stage 
for the production of actively ac-
quired tolerance by Medawar and 
colleagues in the laboratory. These 
investigators injected mouse em-
bryos of the CBA strain in utero 
through the anterior abdominal 
wall with a suspension of living 
spleen cell lymphocytes of the 
A strain (Billingham, Brent and 
Medawar, 1953). The CBA recip-
ients, regularly accepted A-strain 
skin grafts when grafted in adult 
life. This tolerance of A-strain 
grafts was specific, since CBA mice 
tolerant of A-strain tissues easily 
rejected allografts from the unre-
lated AU strain. At the same time, 
Hasek reproduced Owen's observa-
tions in chickens by the ingenious 
method of making a deliberate 
synchorial parabiosis of embryos 
via the chorioallantoic membrane 
(Hasek, 1953). At hatching, the 
parabiots were separated and were 
found to be tolerant not only of 
each other's red cells, but skin allo-
grafts. Subsequently, it was found 
that in utero injection was unneces-
sary, and that intravenous injection 
during the early neonatal period 
also produced tolerance. In these 
experiments tolerance could be 
abolished by the injection of toler-
ant animals with lymphoid cells 
from normal adult members of the 
same syngeneic strain. Further-
more, careful testing showed that 
the tolerant mice were, in fact, 
chimeras insofar as their lymphoid 
cell populations were concerned 
(Billingham, 1958). Tolerance in-
duced in the neonatal period was 
frequently permanent. This was in 
sharp contrast to the transient na-
ture of the tolerance to chemical 
antigens observed by a number of 
other investigators when non-living, 
non-replicating antigens, such as 
proteins, were injected into neonatal 
animals for varying periods from 
birth to adulthood. 
The demonstration by Smith and 
Bridges ( 1958) and Mitchison 
(1959) of the necessity of repeated 
injections of non-replicating anti-
gens to maintain tolerance toward 
these antigens, coupled with the ob-
servation of chimerism in tolerant 
mice in Medawar's experiment, em-
phasized the concept that persist-
ence of antigen was necessary for 
the maintenance of tolerance. 
Another important aspect of tol-
erance induction involves the ge-
netic relationship between the donor 
and the immature host. It was 
found that the more distant the 
histocompatibility relationships be-
tween donor and host, the more 
difficult it was to induce tolerance. 
When strong histocompatibility bar-
riers existed, large innoculums of 
cells were.required, the intravenous 
route was obligatory, and the 
tolerance-responsive period ex-
tended only to a short time after 
birth. On the other hand, when the 
genetic and, therefore, antigenic dis-
parity between donor and host was 
relatively weak, such stringent re-
quirements disappeared. In fact, 
when mice of very weak histocom-
patibility differences were used, the 
tolerance-responsive period ex-
tended even into adulthood (Sha-
piro et al., 1961). 
Graft-Versus-Host Reaction 
Just as the phenomenon of ac-
tively acquired tolerance was dis-
covered in tissue transplantation 
research, so also was the graf !-ver-
sus-host reaction (hereafter, GVH 
reaction) basically an outcome of 
research in immunological toler-
ance. Simonsen (1957) found that 
adult splenic cells, when injected 
into newborn or embryo chickens 
and mice, produced a disease that 
could only be interpreted as an out-
come of an immunological response 
by these grafted cells against the 
host. Simultaneously, Billingham 
and Brent (1957), in their attempts 
to induce tolerance in newborn 
mice, found that, in certain strain 
combinations, all injected mice died 
from a peculiar wasting disease. 
They concluded that a GVH reac-
tion was the likely explanation of 
this pathological condition which 
they named runt disease. GVH re-
actions result when a recipient of 
a graft comprised of immunologi-
cally competent cells is incapable of 
rejecting the cellular ·graft. This sit-
uation typically arises in very young 
individuals (embryos and newborn 
recipients). It also occurs in adults 
when a graft from a homozygous 
donor, i.e., genetically AA, is given 
to a host that is an Fi hybrid be-
tween the donor strain and a dis-
similar strain, i.e., genetically AB. 
A graft A transplanted to an AB 
host represents a situation in which 
the hybrid cannot reject the graft 
by immunological means even 
though the host may be entirely 
competent immunologically. This is 
true because the graft does not 
possess any antigens that are for-
eign to the host. The graft, how-
ever, can react against the host, 
since the latter contains foreign 
antigens derived from the dissimilar 
parent of the hybrid. 
The mouse is the classic animal 
for the production of GVH reac-
tions and runt disease. In se-
vere reactions, mice grow normally 
for about a week, but thereafter 
growth ceases, and there is subse-
quent weight loss, associated with 
diarrhea, alopecia, dermatitis and 
eventual death . This pathological 
condition has been demonstrated 
in numerous other species. It is of 
great clinical significance that hu-
man recipients of bone marrow 
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transplants, especially after immu-
nosuppressive treatment with whole 
body irradiation or cytotoxic drugs, 
have shown all the symptoms of 
classical GVH reactions similar to 
those observed in lower species. The 
most important parameters which 
determine severity of GVH reac-
tions are: 1) the immune compe-
tence of the cells utilized; 2) the 
dose of the cellular innoculum; and 
3) the degree of histocompatibility 
difference between the donor and 
the recipient. The pathological 
symptoms and the mortality rate 
increase as these parameters in-
crease. 
Immunological Tolerance and 
Antilymphocyte Serum 
Induction of specific immunolog-
ical tolerance to either tissue allo-
grafts or non-replicating, chemi-
cally defined antigens, such as 
proteins, is by no means limited to 
neonatal or immunologically in-
competent young animals. Toler-
ance can be induced in adult, im-
munologically competent animals 
under a number of special circum-
stances. For example, it may be 
induced by the injection of massive 
amounts of antigen (so-called im-
munological paralysis or antigen 
overloading) or by the injection of 
antigen during certain times of im-
munosuppression or lymphocyte 
depletion. Immunological depres-
sion in adult animals to abet the 
induction of tolerance has been 
achieved in a number of different 
ways, i.e., irradiation, cytotoxic 
drugs, steroids or a combination 
of these (Russell and Monaco, 
1965) . In our laboratory, heterol-
ogous antilymphocyte serum (ALS) 
has been used as an immunosup-
pressive agent to facilitate the in-
duction of tolerance to tissue allo-
grafts in adult animals. It is the 
purpose of this report to review 
our experiments in this particular 
area. 
Heterologous ALS is an extra-
ordinary immunosuppressive agent. 
Mice treated with this reagent show 
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a dramatic inability to reject tissue 
allografts and xenografts (Gray et 
al., 1966; Monaco et al., 1966). 
Recent evidence indicates that ALS 
acts mainly on peripheral circulat-
ing lymphocytes (Taub and Lance, 
1968) . The mechanism of action 
of ALS continues to be uncertain, 
but evidence suggests (Monaco, 
Wood and Russell, 1965a) that its 
immunosuppressive property de-
pends on its effects on thymus-
dependent, immunologically compe-
tent lymphocytes. ALS frequently 
induces peripheral lymphopenia 
and tissue lymphocyte depletion, 
and the treated animals are non-
specificall y immunosuppressed. 
Some serums, equally immunosup-
pressive, do not necessarily produce 
a dramatic and sustained lympho-
penia. It appears, therefore, that for 
ALS to be immunosuppressive, it 
must act on a select group of pe-
ripheral lymphocytes which is prob-
ably quite small in number, and its 
effectiveness is not dependent on 
the lymphopenia per se, but rather 
on the depletion or destruction of a 
certain population of immunocom-
petent, thymus-dependent cells. Re-
cent work suggests that ALS is 
highly effective in depressing cellu-
lar-type immunities, as typified by 
reaction of tissue allografts, where-
as the humoral antibody response 
to certain antigens, especially bac-
terial ones, is much less affected. 
The depression of immune capa-
bility following treatment with ALS 
may be due to the decreased num-
ber of mature lymphocytes and/ or 
to the immune incompetence of re-
maining lymphocytes. From our 
experiments it appears that the lym-
phoid cells exposed to ALS in vivo 
an din vitro do not live on and rep-
licate (Van der Werf et al., 1968), 
since ,they do not induce GVH re-
actions in susceptible recipients or 
tolerance and chimerism in neona-
tally injected histoincompatible 
mice. This supports the concept that 
the cells remaining in lymph nodes 
after rabbit anti-mouse lymphocyte 
serum (RAMLS) treatment are im-
munologically incompetent. These 
remammg cells (or their descend-
ents) eventually become immuno-
logically competent, perhaps under 
the influence of the thymus or a 
thymic product. 
Experiments have been done in 
mice and rats to determine whether 
or not tolerance is a property asso-
ciated with the thymus or thymus-
derived cells. Galton, Reed and Holt 
(1964) showed that allograft toler-
ance occurs with the achievement 
of thymic chimerism. This sug-
gested that the presence of allo-
geneic cells within the thymus 
is essential for the induction 
and maintenance of a tolerant state 
and that the target cell for toler-
ance induction must be the lym-
phoid precursor cell within the 
thymus. The presence of the anti-
gen within the thymus and the ex-
istence of tolerance may, however, 
be coincidental, as has been sug-
gested by Miller and Osoba ( 1967). 
Other investigators (Follett, Bat-
tisto and Bloom, 1966) have shown 
that the lymphoid system in adult-
thymectomized animals can be 
rendered specifically tolerant to de-
fined antigens. Thus, the pres-
ence of the thymus is not necessary 
for tolerance induction. This does 
not exclude the lymphoid precursor 
cells as the target cells for toler-
ance induction. These may be pres-
ent in the thymus-dependent areas 
of lymphoid organs (Holborrow, 
1968) and be influenced by a thy-
mic humoral factor (Hardy et al., 
1968). The breakdown of tolerance 
occurs when immunologically com-
petent cells are recruited from pre-
cursors which have not been ex-
posed to the tolerance-inducing an-
tigen. This recruitment appears to 
be dependent on the thymus or on 
a thymic humoral factor. Claman 
and Talmage ( 1963) showed that, 
in mice previously rendered toler-
ant to horse serum albumin, adult 
thymectomy delayed the spontane-
ous escape from tolerance. Argyris 
( 1965) showed that the transplan-
tation of C3H/ He thymus tissue 
accelerated the breakdown of tol-
erance in C3H/ He mice tolerant 
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to CBA skin grafts. Goldstein et 
al. have recently shown that toler-
ance to A l Jax skin in neonatally 
thymectomized CBA mice can be 
abolished by a thymic humoral fac-
tor (unpublished data). It appears, 
therefore, that the thymus or a thy-
mic humoral factor plays an im-
portant role in the induction and 
the abolishment of a tolerant state, 
presumably by its influence on the 
development and the recruitment of 
immunologically competent cells. 
Although ALS is highly effective 
in depressing cellular type immuni-
ties-as typified by rejection of tis-
sue allografts-while preserving 
relatively intact the humoral anti-
EXPERIMENTAL PRODUCTION OF CHIMERAS 
0 
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Thym 7. Thymectomy Anti-lymphocyte serum 0 , ... , r , .., 
0 
NO 
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t 
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0 
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TOLERANCE 
Fig. I-The experimental production of chimeras and specific immunological 
tolerance with antilymphocyte serum. (Reprinted from Monaco, Wood and 
Russell, 1966.) 
body responses to certain bacterial 
antigens, it must be emphasized that 
ALS-induced suppression of tissue 
graft rejection is still nonspecific. 
Thus, third-party allografts placed 
on mice treated with ALS while an 
earlier test allograft is alive are re-
jected at the same time as the test 
allografts (Monaco et al., 1966). 
Furthermore, adult thymectomy 
and ALS treatment produce a pro-
longed period of nonspecific im-
mune incompetence in the capacity 
to express cellular type immuni-
ties. Adult-thymectomized, ALS-
treated mice frequently bear healthy 
allografts for over 100 days. Third-
party grafts applied at that time 
also frequently show prolonged 
survival. This profound immune in-
competence induced by adult thy-
mectomy and ALS seemed analo-
gous to the unresponsiveness seen 
in neonatally thymectomized mice. 
Because of this similarity, we felt 
it might be possible to induce tol-
erance in adult animals treated in 
this manner. 
In the initial experiments (Mon-
aco, Wood and Russell, 1966) 
adult-thymectomized and normal 
A l Jax mice were treated with ALS 
and infused with C3H/ He X A/ Jax 
Fi hybrid cells intravenously. Fi hy-
brid cells were used to avoid a GVH 
reaction (Fig. 1). C3H/He skin al-
lografts in adult-thymectomized, 
ALS-treated, cell-infused mice 
showed a markedly prolonged sur-
vival , as compared to a dult-
thymectomized animals receiving 
ALS but no cell infusion. Further-
more, thymectomized, ALS-treated, 
cell-infused mice rejected third-
party C57BL/ 6 J skin in a normal 
fashion while retaining their first 
and, even, second C3H/ He skin 
allografts (Fig. 2). This emphasized 
the fact that they were specifically 
tolerant to C3H/ He tissues. These 
tolerant mice were found to be lym-
phoid cell chimeras, · containing 
lymphocytes of both A/ Jax and 
C3H/He genotypes. The tolerance 
was abolished by injection of nor-
mal (syngeneic) A/ Jax lympho-
cytes, a finding similar to that noted 
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by Medawar and colleagues in their 
tolerance experiments in neonatal 
animals. This acquired state of 
tolerance associated with a state of 
lymphoid cell chimerism was seen 
in all the thymectomized mice 
which received both ALS and a 
cell infusion. 
Since hybrid donor lymphoid 
cells would never be available in 
clinical situations, attempts were 
made to reproduce the above ex-
periment using non-hybrid (homo-
zygous) allogeneic lymphoid ceHs. 
Severe GVH reactions resulted 
when high doses (300 x 106 ) of 
cells were used. To avoid the GVH 
reaction, we used allogeneic histo-
compatibility antigens in a cell-free 
form from the supernatant of 
mechanically disrupted spleen cells 
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(Monaco, Wood and Russell, 
1965b) of the skin graft donor. 
The addition of this cell-free anti-
gen (CPA) to a course of ALS in-
creased the prolongation of skin al-
lografts slightly over that achieved 
with ALS alone. The addition of 
CPA to a course of ALS in adult-
thymectomized mice almost dou-
bled skin allograft survival as com-
pared to that in ALS-treated 
thymectomized mice (Abbott, 
Monaco and Russell, 1969). Of 
major importance was the finding 
that third-party grafts were rejected 
relatively normally in the thymec-
tomized animals receiving ALS and 
CF A, and, therefore, the prolonged 
survival of the original allograft 
was a form of specific acquired tol-
erance in the adult. 
The tolerance induced with CPA 
in such lymphocyte-depleted ani-
mals may be long lasting but is not 
permanent. Furthermore, the num-
ber of animals in any group show-
ing a great degree of tolerance is 
less than when replicating lymphoid 
cells are used as the donor antigen. 
Presumably this results from a re-
generation or increase in the num-
ber of immunologically competent 
cells which can, again, react to the 
foreign antigen. Since these cells 
are probably thymus-dependent, as 
we indicated earlier in this article, 
one may justifiably question the 
reappearance of immunocompetent 
cells in an ALS-treated thymectom-
ized mouse. It is probable that a 
small number of immunologically 
competent cells can regenerate from 
Fig. 2- A. An adult-thymectomized A/ Jax mouse which received ALS for seven days followed by 300 x lQG C3H/ He lym-
phoid cells, as in Figure 1. The mouse bears a C3H/ He graft in perfect condition for 100 days. 
B. The same mouse bearing the same first C3H/ He graft as well as a second C3H/ He graft on day 150. 
C. A similar adult-thymectomized, ALS-treated, cell-infused mouse bearing a perfect C3H/ He graft over 100 days but 
simultaneously rejecting a third-party C57Bl / 6J skin allograft-i.e., indicating specific tolerance. 
D. The mouse visualized in B after infusion with normal syngeneic A/Jax lymphoid cells, showing rejection of previ-
ously well-tolerated C3H/ He grafts-Le., the abolition of specific tolerance. 
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the bone marrow in the absence of 
the thymus. Another possibility is 
that residual stem cells in the pe-
ripheral lymphoid system (lymph 
nodes, Peyer's patches, etc.) may 
differentiate to immunologically 
competent cells under the influence 
of a thymic humoral factor which 
persists in such tissues after thy-
mectomy. It may be possible to 
circumvent this regeneration by the 
addition of small doses of immu-
nosuppressive agents (perhaps in 
association with specific antigen) to 
prevent the regeneration of new 
immunocompetent cells. Appar-
ently, when a chimeric state is 
established, regeneration of com-
petent cells and loss of the tolerant 
state is delayed or prevented by 
persisting donor antigen in the 
form of chimeric lymphoid cells. 
Until recently we were unable 
to induce any form of specific tol-
erance in the non-thymectomized, 
ALS-treated adult mice. On the 
contrary, we found that such ani-
mals were sensitized after infusion 
with allogeneic F1 hybrid lymphoid 
cells. These seemingly incompatible 
results may be explained by Mitchi-
son's ( 1965) elegant demonstration 
that the antigen dose frequently 
determines whether tolerance or 
sensitization results from antigen 
introduction. This investigator 
showed that tolerance to bovine 
serum albumin in mice resulted 
when the protein was administered 
in two dose zones, i.e., in high and 
low ranges. Doses in other ranges 
either produced sensitization or no 
effect. The concept of high zone and 
low zone tolerance was thus intro-
duced. We tested the effects of vari-
ous doses (0.01, 0.1, 1.0, 10 and 
100 X 106 ) of homozygous allo-
geneic C3HjHe lymphoid cells in 
five groups of ALS-pretreated (non-
thymectomized) A/ Jax mice. Con-
trols received ALS but no cells. 
Figure 3 shows the survival curves 
of the test allografts in the various 
groups. C3HjHe skin allografts sur-
vived longest in AjJ ax mice which 
received 10 x 106 cells, thus indicat-
ing a potentiation of ALS immuno-
OAYS 8 12 16 20 24 28 32 36 40 48 52 56 so 64 se n 
Fig. 3-Survival curves of C3H/ He skin allografts on ALS-treated A/ Jax mice 
infused with various doses of C3H/He allogeneic, non-F1 hybrid lymphoid cells. 
(Monaco, in press, 1969.) 
suppression by cell infusion, i.e., 
partial tolerance. The grafts in the 
groups receiving 0.1 X 106 or 100 
X 106 had a shorter survival time 
than the ALS controls, indicating 
a partial sensitization by this dose 
of cell infusion. Mice receiving .01 
x 106 or 1 x 106 cells rejected 
their grafts at the same time as the 
controls treated with ALS alone, 
showing that there was no effect of 
doses of cells in these ranges. These 
observations in ALS-treated mice 
receiving cell infusions are analo-
gous to those of Mitchison on vari-
ous protein antigens in which the 
resulting reactions of sensitization 
and/ or tolerance are probably de-
pendent on the dose of antigen 
utilized. Of importance in these 
experiments, from the point of view 
of potential clinical application, was 
the observation that in these lower 
dose ranges where partial tolerance 
resulted, there was little if any ob-
served GVH reaction. 
Lance and Medawar (1969), in 
a similar experiment, have em-
phasized the effect of the timing of 
injections of cells on the probability 
of their potentiating or sensitizing 
the recipient of the graft. Further-
more, these investigators demon-
strated that GVH reactions can be 
avoided by using cells with de-
creased immune competence, i.e., 
thymocytes, bone marrow cells, and 
cells from ALS-treated donors. 
That this phenomenon of ac-
quired partial tolerance induced 
with donor antigen is not peculiar 
to skin allografts in mice is well 
established. Organ allografts ap-
pear to be less antigenic than skin 
allografts; hence, it will probably 
·be easier to develop a tolerant state 
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to an organ allograft than to a 
skin allograft. We must further re-
member that organs are attached by 
direct vascular anastomosis and 
that the antigen is chronically re-
leased. This may be important in 
maintaining a tolerant state. Thus, 
a permanent state of chimerism 
might not be necessary to achieve 
a permanent state of tolerance. 
Seifert et al. (1966) obtained sig-
nificant improvement in renal allo-
grafts by pretreating dogs with 
subcellular (cell-free) antigen and 
6-mercaptopurine and a dding 
methylprednisolone after trans-
plantation. Dagher et al. ( 1967) 
used a two-week pretreatment 
course with soluble cytoplasmic an-
tigen from viable donor spleen cells 
and demonstrated a prolonged renal 
allograft survival in dogs when 
minimal doses of azathioprine and 
methylprednisolone were given after 
renal transplantation. These studies 
of whole organ allograft survival 
suggest that the prolongation was 
augumented by the donor antigen. 
The use of specific donor antigen 
appears promising as an adjunct 
in immunosuppressive therapy of 
whole organ allografts. 
Conclusion 
Our interest in the problem of 
tolerance induction is directly con-
cerned with clinical organ trans-
plantation. ALS is highly effective 
in depressing cellular immunities. 
Since at least initial allograft rejec-
tion is predominantly a cellular 
phenomenon, one would expect 
ALS to be highly effective clinically. 
Our initial observations in this re-
gard support this concept. However, 
non-specific depression of cellular 
immunity may also lead to an in-
creased number of viral, fungal, 
and protozoan infections. Experi-
ments, such as those presented, 
strongly suggest that a specific state 
of tolerance to organ grafts in man 
should be attainable with the aid of 
ALS followed by introduction of 
appropriate antigen. A number of 
avenues are open to increase the 
likelihood of success for clinical in-
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duction of tolerance. Improved 
methods of histocompatibility typ-
ing will aid in tolerance induction, 
since tolerance is more easily estab-
lished when histocompatibility dif-
ferences are minimized. Much effort 
is being expended in isolation of hu-
man cell-free histocompatibility an-
tigens in a soluble form (Kahan and 
Reisfeld, 1969). Experimental evi-
dence so far suggests that soluble 
antigens are less immunogenic and 
more tolerogenic. Development of 
optimal (non-sensitizing, toleroge-
nic) antigenic dose schedules-to 
be administered after immunosup-
pression has been achieved-should 
facilitate clinical tolerance induc-
tion. If antigens are utilized in a 
cellular form-as is our tendency at 
present-then replicating lymphoid 
cells from ALS-treated donors, rep-
licating non-immunologically com-
petent cells ( thymocytes, bone 
marrow cells), or nonreplicating 
parenchymal cells of appropriate 
organs (liver, kidney, etc.) might, 
theoretically, be utilized. It is ap-
parent that organ transplantation 
cannot be fully applied until the 
problem of specific allograft tol-
erance is solved. A practical solu-
tion to the problem may be closer 
at hand than we realize. 
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